Assessing Preferences of Patients with Chronic Spontaneous Urticaria for Injectable Treatment Profiles.

ABSTRACT:

Background

In the context of injectable biologic products approved or in development for chronic spontaneous urticaria (CSU), it is important to capture which treatment attributes matter most to patient and what trade-offs patients are willing to make.

Objectives

The CHOICE-CSU study aimed to quantify patient preferences toward injectable treatment attributes among patients with CSU, inadequately controlled by H1-antihistamines.

Methods

This was a two-phase cross-sectional patient preference study in adult patients with a diagnosis of CSU, inadequately controlled by H1-antihistamines. A qualitative phase collected patients' insights and relevant treatment attributes that mattered to them, and the outputs were used for the quantitative phase to create the actual inject

SUBMITTER: Gimenez-Arnau AM 

PROVIDER: S-EPMC11832561 | biostudies-literature | 2025 Mar

REPOSITORIES: biostudies-literature